A brief introduction to nuclear medicine and an overview of the radionuclides used in nuclear medicine were provided in Chapter 3A (Venkatesh and Kang, 2020). This article, a sequel to Chapter 3A, provides an overview of the radiopharmaceuticals and their uses in nuclear medicine. The biological...
Molecular imaging using radiopharmaceuticals uses some of the most advanced imaging technologies available today, providing physicians with valuable information in the assessment and extent of disease. As one of the most highly used diagnostic methods, nuclear medicine is a crucial tool when evaluating ca...
Easy access to detailed information on medications, radioactive and non-radioactive, used in nuclear medicine. View now Industry perspective on FDA-approved radiopharmaceuticals Statements from key industry groups that outline recommended guidelines on nuclear pharmacy compounding and the use of FDA-approve...
Most radiopharmaceuticals are used for the purpose of medical diagnosis. They usually contain only small amounts of the active substances with a radionuclide attached to them to allow scintigraphic im 关键词: Radioisotopes Pharmaceutical Preparations Drug Compounding Nuclear Medicine DOI: 10.1007/978-3-...
Radiopharmaceuticals are used in nuclear medicine for diagnostic and therapeutic purposes. Many adverse reactions and false positive reactions related to radiopharmaceuticals take place every day in hospitals, but most of them are not reported. It is therefore important to understand the definition of eac...
according to a survey conducted in the study 'Nuclear medicine volume plummets due to COVID-19' published in September 2020, the scheduled diagnostic and therapeutic nuclear imaging procedures were quantitatively reduced by 50% to 75% respectively in the United States during the pandemic. Thus,...
Diagnostic imaging is the bread and butter of the nuclear medicine practice, deHoll explained. Approximately 90% of all procedures conducted using radiopharmaceuticals are diagnostic in nature. The most commonly used radiopharmaceuticals in diagnostics are Tc-99m sestamibi and Tc-99...
“Working with NorthStar, a proven leader in nuclear medicine innovation and production, we believe that together we can ensure timely and efficient progression of our programs towards the clinic, and give patients broader access to potentially life-saving therapies." For more information:...
Labelled Compounds and radiopharmaceuticals applied in nuclear medicine by A. T. Balaban, I. Galateanu, G. Georgescu and L. Simionescu Published by Editura Academici, Bucuresti, and John Wiley et Sons Ltd., Chichester, 1986, 742 pages Price: £70.00 (US $115.50) ISBN 0 471 90458 9 ...
This can be used in nuclear medicine for diagnosis and therapy of pituitary diseases [46]. P-glycoprotein (ABCB1, MDR1) is well-known in terms of its function for multidrug resistance of tumors [31, 33]. Two major therapy concepts have been developed with P-glycoprotein as target molecule...